MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jchf.2023.01.008

Медицинская библиотека · JACC. Heart failure · 2023

Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial.

Chieng David, Sugumar Hariharan, Segan Louise, Tan Caleb, Vizi Donna, Nanayakkara Shane, Al-Kaisey Ahmed, Hawson Joshua, Prabhu Sandeep, Voskoboinik Aleksandr, Finch Sue, Morton Joseph B, Lee Geoffrey, Mariani Justin, La Gerche Andre, Taylor Andrew J, Howden Erin, Kistler Peter M, Kalman Jonathan M, Kaye David M, Ling Liang-Han

Рандомизированное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients with heart failure with preserved ejection fraction (HFpEF) frequently develop atrial fibrillation (AF). There are no randomized trials examining the effects of AF ablation on HFpEF outcomes.

OBJECTIVES

The aim of this study is to compare the effects of AF ablation vs usual medical therapy on markers of HFpEF severity, including exercise hemodynamics, natriuretic peptide levels, and patient symptoms.

METHODS

Patients with concomitant AF and HFpEF underwent exercise right heart catheterization and cardiopulmonary exercise testing. HFpEF was confirmed with pulmonary capillary wedge pressure (PCWP) of 15 mm Hg at rest or ≥25 mm Hg on exercise. Patients were randomized to AF ablation vs medical therapy, with investigations repeated at 6 months. The primary outcome was change in peak exercise PCWP on follow-up.

RESULTS

A total of 31 patients (mean age: 66.1 years; 51.6% females, 80.6% persistent AF) were randomized to AF ablation (n = 16) vs medical therapy (n = 15). Baseline characteristics were comparable across both groups. At 6 months, ablation reduced the primary outcome of peak PCWP from baseline (30.4 ± 4.2 to 25.4 ± 4.5 mm Hg; P < 0.01). Improvements were also seen in peak relative VO2 (20.2 ± 5.9 to 23.1 ± 7.2 mL/kg/min; P < 0.01), N-terminal pro-B-type natriuretic peptide levels (794 ± 698 to 141 ± 60 ng/L; P = 0.04), and MLHF (Minnesota Living with Heart Failure) score (51 ± -21.9 to 16.6 ± 17.5; P < 0.01). No differences were detected in the medical arm. Following ablation, 50% no longer met exercise right heart catheterization-based criteria for HFpEF vs 7% in the medical arm (P = 0.02).

CONCLUSIONS

AF ablation improves invasive exercise hemodynamic parameters, exercise capacity, and quality of life in patients with concomitant AF and HFpEF.

Для цитирования: Chieng David, Sugumar Hariharan, Segan Louise, Tan Caleb, Vizi Donna, Nanayakkara Shane, Al-Kaisey Ahmed, Hawson Joshua, Prabhu Sandeep, Voskoboinik Aleksandr, Finch Sue, Morton Joseph B, Lee Geoffrey, Mariani Justin, La Gerche Andre, Taylor Andrew J, Howden Erin, Kistler Peter M, Kalman Jonathan M, Kaye David M, Ling Liang-Han. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial.. JACC. Heart failure. 2023. DOI: 10.1016/j.jchf.2023.01.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.